Long-term Follow-up of Opicapone Use as Add-on to Levodopa in Parkinson&#39;s Patients Without Motor Fluctuations: Findings from the EPSILON Study

Ongentys (opicapone) - Ono Pharma, Neurocrine, BIAL

https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-002636.html

Joaquim Ferreira1; Olivier Rascol2; Fabrizio Stocchi3; Angelo Antonini4; Paloma Lapuente5; Guillermo Castilla-Fernández5; Helena Brigas5; Ghazal Banisadr6; José-Francisco Rocha5; Joerg Holenz5; Werner Poewe7

Mar 8, 2025